Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform

Alzheimer's and Dementia

Volumn 11, Issue 9, 2015, Pages 1121-1122

  Vaudano, Elisabetta ^a   Vannieuwenhuyse, Bart ^b   Van Der Geyten, Serge ^b   Van Der Lei, Johan ^c   Visser, Pieter Jelle ^d   Streffer, Johannes ^b   Ritchie, Craig ^e   McHale, Duncan ^f   Lovestone, Simon ^g   Hofmann Apitius, Martin ^h   Truyen, Luc ^b   Goldman, Michel ⁱ  

^a Innovative Medicines Initiative (IMI)   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UCB PHARMA   (Belgium)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h FRAUNHOFER INSTITUTE FOR ALGORITHMS AND SCIENTIFIC COMPUTING SCAI   (Germany)

ⁱ UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; BUDGET; DEGENERATIVE DISEASE; DRUG INDUSTRY; FUNDING; HIGH RISK POPULATION; HUMAN; LIFE EXPECTANCY; METABOLIC DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; SECONDARY PREVENTION; TRANSLATIONAL RESEARCH; DRUG DEVELOPMENT; EUROPE; INFORMATION DISSEMINATION; METABOLISM; PROCEDURES;

ALZHEIMER DISEASE; BIOMARKERS; DRUG DISCOVERY; EUROPE; HUMANS; INFORMATION DISSEMINATION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84942195152     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.02.002     Document Type: Letter

References (0)